Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Dehm

Showing results (71-80 of 129) with videos related to

Pageof 13
Sort By:
Prostate Cancer and Prostatic Diseases|June 3, 2018
Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patientsManish Kohli, Jian Li, Meijun Du, et al.
Journal of Extracellular Vesicles|October 9, 2025
Proteomic Profiling of Extracellular Vesicles Distinguishes Prostate Cancer Molecular SubtypesMegan L Ludwig, Ali T Arafa, Saasha Vinoo, et al.
Science Advances|February 28, 2024
Stat5 induces androgen receptor (<i>AR</i>) gene transcription in prostate cancer and offers a druggable pathway to target AR signalingCristina Maranto, Lavannya Sabharwal, Vindhya Udhane, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Proteomic profiling of extracellular vesicles distinguishes prostate cancer molecular subtypesMegan L Ludwig, Ali T Arafa, Saasha Vinoo, et al.
Oncotarget|August 25, 2016
CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumorsKhalil Ahmed, Betsy T Kren, Md Joynal Abedin, et al.
JCI Insight|August 29, 2024
Androgen production, uptake, and conversion (APUC) genes define prostate cancer patients with distinct clinical outcomesHannah E Bergom, Ella Boytim, Sean McSweeney, et al.
Cancers|January 8, 2025
Isolation of Plasma Extracellular Vesicles for High-Depth Analysis of Proteomic Biomarkers in Metastatic Castration-Resistant Prostate Cancer PatientsAli T Arafa, Megan Ludwig, Onur Tuncer, et al.
Urology|December 29, 2020
Prostate Cancer Foundation Hormone-Sensitive Prostate Cancer Biomarker Working Group Meeting SummaryMartin R Hofmann, Maha Hussain, Scott M Dehm, et al.
Cell Reports|September 11, 2025
Disrupting the interaction between androgen receptor and its coregulator WDR77 delays the growth of treatment-resistant prostate cancerUjjwal R Dahiya, Sangeeta Kumari, Nidhi Singh, et al.
NPJ Precision Oncology|September 30, 2024
Integrated multi-omics assessment of lineage plasticity in a prostate cancer patient with brain and dural metastasesMegan L Ludwig, David Moline, Alec Horrmann, et al.
Pageof 13

Showing results (71-80 of 129) with videos related to

Sort By:
Pageof 13
Prostate Cancer and Prostatic Diseases|June 3, 2018
Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patientsManish Kohli, Jian Li, Meijun Du, et al.
Journal of Extracellular Vesicles|October 9, 2025
Proteomic Profiling of Extracellular Vesicles Distinguishes Prostate Cancer Molecular SubtypesMegan L Ludwig, Ali T Arafa, Saasha Vinoo, et al.
Science Advances|February 28, 2024
Stat5 induces androgen receptor (<i>AR</i>) gene transcription in prostate cancer and offers a druggable pathway to target AR signalingCristina Maranto, Lavannya Sabharwal, Vindhya Udhane, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Proteomic profiling of extracellular vesicles distinguishes prostate cancer molecular subtypesMegan L Ludwig, Ali T Arafa, Saasha Vinoo, et al.
Oncotarget|August 25, 2016
CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumorsKhalil Ahmed, Betsy T Kren, Md Joynal Abedin, et al.
JCI Insight|August 29, 2024
Androgen production, uptake, and conversion (APUC) genes define prostate cancer patients with distinct clinical outcomesHannah E Bergom, Ella Boytim, Sean McSweeney, et al.
Cancers|January 8, 2025
Isolation of Plasma Extracellular Vesicles for High-Depth Analysis of Proteomic Biomarkers in Metastatic Castration-Resistant Prostate Cancer PatientsAli T Arafa, Megan Ludwig, Onur Tuncer, et al.
Urology|December 29, 2020
Prostate Cancer Foundation Hormone-Sensitive Prostate Cancer Biomarker Working Group Meeting SummaryMartin R Hofmann, Maha Hussain, Scott M Dehm, et al.
Cell Reports|September 11, 2025
Disrupting the interaction between androgen receptor and its coregulator WDR77 delays the growth of treatment-resistant prostate cancerUjjwal R Dahiya, Sangeeta Kumari, Nidhi Singh, et al.
NPJ Precision Oncology|September 30, 2024
Integrated multi-omics assessment of lineage plasticity in a prostate cancer patient with brain and dural metastasesMegan L Ludwig, David Moline, Alec Horrmann, et al.
Pageof 13